Skip to content
★ Sign in to follow
Sinsin Pharmaceutical Co., Ltd logo

Sinsin Pharmaceutical Co., Ltd Stock: price and insider trades · South Korea

신신제약

KR·Mcap ₩61.7BHealth Care

No insider purchase over the last 90 days. The latest, by 김상경, was filed 01 Jul 2026.

Sinsin Pharmaceutical Co., Ltd: what insiders have been doing

Sinsin Pharmaceutical Co., Ltd belongs to the Health Care sector. Filings by its managers are published through DART (FSS). In the past year (1 November 2025 to 1 November 2026), 3 filings came from 3 insiders.

No insider sold shares on the market over the period. Instead, the filings list 1 purchase, made by 1 insider. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 1 board member.

Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 3 filings, this issuer sits below that mark. Since 2021, the database holds 4 purchases and 2 sales by insiders of the company.

The last insider purchase was made public on 1 July 2026, 132 days ago.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.

Insider Decl.
26
Thresholds
n/a
Buy Volume
€39,543
4 ops. · all time
Sell Volume
€19,992
2 ops. · all time

Who traded when

BuySale
김상경1 buy
신성학1 sale
윤광철1 sale
Fundamental score
Ranked 3,065 of 26,911 companies
72.9
score / 100
Value
85
Quality
61
FCF yld11%
Earn yld15%
EV/EBITDA6.8x
ROE18%
Gross mgn38%
Net mgn8.2%
Debt/EBITDA2.8x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩4,070
Analyst consensus
·
Income statement
Revenue₩113.8B
Gross profit₩43.1B38% margin
EBITDA₩15.6B14% margin
Net income₩9.3B10.9% margin
Valuation
Beta0.22
Balance sheet & cash
Market cap₩61.7B
Total debt₩43.7B
Free Cash Flow₩7B
Debt / Equity51%
Profitability & ownership
ROE18.3%
ROA6.6%
% insiders51.9%
% institutions0.0%
Last declaration on 1 July 2026
Declarations26 total
  • ▲
    전무이사Executives(filed)
    €5,371est.0DART
    2,200 sharesShareKRXDART:20260701000554
    Canonical exit: 29 Sept 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    0DART
    0KRXDART:20260210000717
  • ▼
    전무이사Executives(filed)
    €16kest.0DART
    5,000 sharesShareKRXDART:20251029000294
  • ▼
    이사Executives(filed)
    €4,065est.0DART
    1,200 sharesShareKRXDART:20251002000542
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    0DART
    0KRXDART:20230621000075
  • ●
    Executives
    0DART
    0KRXDART:20230614000305
  • ●
    전무이사Executives
    0DART
    ShareKRXDART:20230614000333
  • ●
    Executives
    0DART
    0KRXDART:20230612000223
  • ●
    전무이사Executives
    0DART
    ShareKRXDART:20230531000252
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives
    €21kest.0DART
    5,000 sharesShareKRXDART:20230210000252
    Canonical exit: 7 May 2023 (T+90)
  • ▲
    Executives
    €5,000est.0DART
    1,200 sharesShareKRXDART:20230106000102
    Canonical exit: 1 Apr 2023 (T+90)
  • ▲
    Executives
    €8,333est.0DART
    2,000 sharesShareKRXDART:20230106000093
    Canonical exit: 1 Apr 2023 (T+90)
  • ●
    전무이사Executives(filed)
    0DART
    ShareKRXDART:20221223000478
  • ●
    Executives(filed)
    0DART
    0KRXDART:20221223000464
  • ●
    전무이사Executives(filed)
    0DART
    ShareKRXDART:20221223000347
  • ●
    Executives(filed)
    0DART
    0KRXDART:20221223000324
  • ●
    전무이사Executives(filed)
    0DART
    ShareKRXDART:20220919000283
  • ●
    전무이사Executives(filed)
    0DART
    ShareKRXDART:20220503000223
  • ●
    전무이사Executives(filed)
    0DART
    ShareKRXDART:20220323000871
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    전무이사Executives(filed)
    0DART
    ShareKRXDART:20220216000971
  • ●
    Executives
    Executives(filed)
    0DART

25 of 26 declarations

About Sinsin Pharmaceutical Co., Ltd

신신제약 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and marketing of pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations